Familial hypercholesterolaemia: what you need to know about the MBS listed genetic test and the latest treatment updates

New guidance for familial hypercholesterolaemia (FH) signal the shift into the era of genetic medicine for cardiologists say specialists who foresee increased numbers of individuals being identified with heritable gene mutations from publicly funded genetic testing that came into effect last year. The updated Guidance released earlier this year covers updates in diagnosis and genetic testing, ...

Already a member?

Login to keep reading.

© 2021 the limbic